- Home
- LXRX vs LSAK Comparison
LXRX vs LSAK Comparison
Compare LXRX & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- LSAK
- Stock Information
- Founded
- LXRX 1995
- LSAK 1997
- Country
- LXRX United States
- LSAK South Africa
- Employees
- LXRX N/A
- LSAK N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- LSAK Investment Bankers/Brokers/Service
- Sector
- LXRX Health Care
- LSAK Finance
- Exchange
- LXRX Nasdaq
- LSAK Nasdaq
- Market Cap
- LXRX 428.8M
- LSAK 344.5M
- IPO Year
- LXRX 2000
- LSAK N/A
- Fundamental
- Price
- LXRX $1.19
- LSAK $4.75
- Analyst Decision
- LXRX Buy
- LSAK
- Analyst Count
- LXRX 5
- LSAK 0
- Target Price
- LXRX $3.23
- LSAK N/A
- AVG Volume (30 Days)
- LXRX 2.4M
- LSAK 21.5K
- Earning Date
- LXRX 08-06-2025
- LSAK 09-03-2025
- Dividend Yield
- LXRX N/A
- LSAK N/A
- EPS Growth
- LXRX N/A
- LSAK N/A
- EPS
- LXRX N/A
- LSAK N/A
- Revenue
- LXRX $58,432,000.00
- LSAK $574,080,000.00
- Revenue This Year
- LXRX N/A
- LSAK $1.06
- Revenue Next Year
- LXRX N/A
- LSAK $13.32
- P/E Ratio
- LXRX N/A
- LSAK N/A
- Revenue Growth
- LXRX 1504.83
- LSAK 4.13
- 52 Week Low
- LXRX $0.28
- LSAK $3.39
- 52 Week High
- LXRX $2.18
- LSAK $5.60
- Technical
- Relative Strength Index (RSI)
- LXRX 56.85
- LSAK 57.33
- Support Level
- LXRX $1.12
- LSAK $4.49
- Resistance Level
- LXRX $1.27
- LSAK $4.79
- Average True Range (ATR)
- LXRX 0.09
- LSAK 0.16
- MACD
- LXRX -0.00
- LSAK 0.00
- Stochastic Oscillator
- LXRX 68.00
- LSAK 69.33
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.